SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 201.18+8.5%Feb 6 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bwe who wrote (689)7/8/1998 5:21:00 PM
From: Hong-Lee Yu   of 1686
 
I believe that we will see BGEN reach 60 very soon if Avonex sales reach 85+M (which I think it will). Recently BGEN fundamentals have been improved dramatically with renewed growth of Avonex both in Europe and USA (7000 new patients in Q2), extended and growing royalty and strong pipelines.

Even with the recent gain, BGEN still trade about 22 against 1999 earnings, less than its growth rate (25%+)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News